Choosing the right tokenizer is a non-trivial task, especially in the biomedical domain, where it poses additional challenges, which if not resolved means the propagation of errors in successive Natural Language Processing analysis pipeline. This paper aims to identify these problematic cases and analyze the output that, a representative and widely used set of tokenizers, shows on them. This work will aid the decision making process of choosing the right strategy according to the downstream application. In addition, it will help developers to create accurate tokenization tools or improve the existing ones. A total of 14 problematic cases were described, showing biomedical samples for each of them. The outputs of 12 tokenizers were provided and discussed in relation to the level of agreement among tools.
Introduction
Tokenization is considered the first step in Natural Language Processing (henceforth, NLP) and it is broadly defined as the segmentation of text into primary building blocks for subsequent analysis (Webster and Kit, 1992) .
Tokenization may seem simple if we assume that all it involves is the recognition of a space as a word separator (Baeza-Yates and Ribeiro-Neto, 2011) . However, a closer examination will make it clear that a blank space alone is not enough even for general English (Jurafsky and Martin, 2009) . Furthermore, choosing the right tokenization strategy is a non-trivial task, especially in the biomedical domain where it poses additional challenges (He and Kayaalp, 2006) which if not resolved means the propagation of errors in successive NLP analysis pipeline. As a consequence, text mining modules, such as Named Entity Recognition, will inevitably suffer in terms of effectiveness (Tomanek et al., 2007) .
Tokenization in biomedical literature is particularly difficult due to the fact that general English differ from biomedical text in vocabulary and grammar (Barrett, 2012) . In addition, scientific information has a particular structure (Harris, 2002) . For example, Campbell and Johnson (2001) carried out three experiments to evaluate the syntactic dissimilarities between medical discharge summaries and everyday English, showing significant differences in syntactic content and complexity.
Another feature of the biomedical literature is related to terminology, which is inconsistently spelt and may vary from typographical errors to lower case and capitalized medication names (Krauthammer and Nenadic, 2004) . Furthermore, biomedical texts could be ungrammatical (especially, clinical documents) as well as often include abbreviations and acronyms. Biomedical terms contain digits, capitalized letters within words, Latin and Greek letters, Roman digits, measurement units, list and enumerations, tabular data, hyphens and other special symbols. In addition, another complexity is the ambiguity, i.e., words and abbreviations that have different meanings (homonymy) and concepts described in more than one way (synonymy). For these reasons, the identification of terminology in the biomedical literature is one of the most challenging research topics in the last few years in NLP and biomedical communities and tokenization plays an important role in handling them.
There is no widely accepted tokenization method for English text, including biomedical documents since tokenization strategies can vary depending on language, task goals and other criteria. Previous approaches to biomedical tokenization lack guidance on how to modify existing tokenizers to new domains and how even to select them. Their idiosyncratic nature, detailed above, complicates this selection, modification and implementation (Barrett, 2012) . Some authors also highlight the clear need for tokenization evaluation through the alignment and com-parison of the results of different tokenizers (Habert et al., 1998) . To address this challenge, this paper identifies and describes all the problematic cases that can be found when tokenizing a biomedical text. In addition, it includes a list of useful tokenizers and a comparison of their outputs on biomedical text samples.
The rest of the paper is organized as follows. Firstly, the most relevant related research is outlined. Secondly, the tokenizers are listed and their outputs are shown. The paper finishes with conclusions.
Related Work
Despite its importance, tokenization is often neglected in the literature (Dridan and Oepen, 2012) . Most research has been focused on annotating corpus with token information (Ohta, et al., 2002; Tanabe et al., 2005; Verspoor, et al., 2012) and developing or adapting tokenizers to new domains (Tomanek et al., 2007; McClosky and Charniak, 2008) . However, little attention has been paid to the analysis of the problematic cases that appear in the tokenization process and the different strategies used for the current available tokenization tools to solve them.
To the best of our knowledge, for the biomedical domain, there is only one work devoted to a comparison of several tokenizers (He and Kayaalp, 2006) . In this study, He and Kayaalp made a first approximation of the challenging cases. As authors affirmed, it can be considered as a starting point since the limited scope of their effort prevented them from developing a more complete set of cases. Especially, the instances identified for biomedical named entities are insufficient. The study also includes a comparison of the output of 13 tokenizers on 78 biomedical abstracts from Medline, a corpus of biomedical literature compiled by the U.S. National Library of Medicine.
Due to the limitations in the categorization of the complex cases and the fact that many tokenization tools have been developed in recent years, this paper complete all these cases, update the list of tokenization tools and test them on a set of biomedical sentences, outlining the differences among tokenization schemes. This means, providing a qualitative guideline for the reader which aid the decision making process of choosing the right tokenizer. This decision will depend mainly on the downstream task. In addition, the critical issues identified, allow developers to know what should be taken into account when adapting or developing tokenization tools.
Material and Methods

Problematic cases
We could divide the potential complexities in the tokenization process into two major categories: those that apply across all domains and those that are more likely to be found in biomedical corpora, where there is a large amount of technical vocabulary (Clegg, 2008) . All these difficulties, together with sentences extracted from the BioScope corpus (Vincze et al., 2008) , in which authors such as Velldal et al. (2012) found problematic cases where tokenizers fail, are detailed below:
Common English complexities
 Hyphenated compound words For example:
(1) Normal chest x-ray.
(2) 2-year 2-month old female with pneumonia. 
 Words with letters and slashes
Slashes usually indicate alternatives (e.g. differentiation/activation) or measurement units (e.g. ng/ml). In addition, they often separate two or more entity references (e.g. IL-12/CD34). They may also denote the knock-out status of a certain gene with respect to an organism (e.g. flt3L-/-mice) (Tomanek et al., 2007 
 Chemical substances
They include several symbols which may (or may not) denote word token boundary symbols such as parentheses, hyphens and slashes (Tomanek et al., 2007) . Furthermore, chemical substances basically comprehend gene symbols, drug names and protein names, each of which has certain characteristics as described below.
Gene symbols
The names can indeed be divided into the following three categories (Proux et al., 1998 The outputs, for which there is no agreement among several tools and, therefore, correspond to a single tokenizer, are not shown in this paper due to the space limit. However, this information can be found in Supplementary Material. Normalchestx-ray. (Carreras, 2004; Padró and Stanilovsky, 2012) http://nlp.lsi.upc.edu/freeling/ 2 Genia (Kulick et al., 2004; http://www.nactem.ac.uk/tsujii/GENIA/tagger/ 3 GUT (Cunningham et al., 2002)  Words with letters and apostrophes 2, 4, 6, 8, 9, 10, 11, 12 Small,scarredrightkidney, belowmorethan2standard deviationsinsizeforpatient's age.
Common English complexities  Hyphenated compound words
3, 5, 7
Small,scarredrightkidney, belowmorethan2standard deviationsinsizeforpatient's age.
 Words with letters and brackets Thetranscriptsweredetectedinall theCD4-CD8-,CD4+ CD8+,CD4+CD8-,and CD4-CD8+cellpopulations.  Words with letters and numbers 2, 4, 5, 6, 7, 8, 9, 11, 12 Selenocysteineandpyrrolysineare the21stand22ndaminoacids, whicharegeneticallyencodedby stop codons.
 Abbreviations in capital letters and acronyms
 Words with letters and periods
 Words with numbers and one type of punctuation , 5, 6, 8, 9, 10, 11, 12 Atotalof26,003iORFsatisfied theabovecriteria.
2, 3, 4, 7
Atotalof26,003iORFsatisfied theabovecriteria. 2, 6, 8, 9, 11, 12 Thepatienthadpriorx-rayon 1/2whichdemonstratedno pneumonia.
4, 5, 7
Thepatienthadpriorx-ray on1/2whichdemonstratedno pneumonia.
3, 10
Thepatienthadpriorx-rayon 1/2whichdemonstratedno pneumonia. 3, 4, 5, 6, 7, 8, 9, 10, 11 Indeed,ithasbeenestimated recentlythatthecurrentyeastand humanproteininteractionmaps areonly50%and10% complete,respectively18. BcdmRNAtranscriptsof&lt; or=2.6kbwereselectively expressedinPBLandtestisof healthyindividuals.
9, 12
BcdmRNAtranscriptsof&lt; or=2.6kbwereselectively expressedinPBLandtestisof healthyindividuals.
3, 7
BcdmRNAtranscriptsof&lt; or=2.6kbwereselectively expressedinPBLandtestisof healthyindividuals.
 A URL 
Conclusions
This paper analyzed the problematic cases that can be found when tokenizing a biomedical text. In addition, it listed a set of potentially useful tokenizers and tested them on biomedical sentences.
Identifying the complex cases that introduce this domain and knowing what types of behavior are expected from available tokenizers in each of these cases is vital. This will enable researchers to be aware of those aspects which are especially challenging when developing new tools or adapting existing ones. In addition, it will aid the process of selecting the right tokenizer according to the most appropriate tokenization scheme for the downstream application. This will facilitate to lose the minimum of information. Obviously, other factors like technical, usability of functional criteria should be taken into account in such decision.
The experiments carried out showed a widely variation on the results. This variability was expected since there is no a single tokenization method. Neither of the tools produced identical output. Tokenizers pair that coincided in the same strategy or scheme in over 75% of cases were Genia tagger and NLTK tokenizer as well as Stanford POS tagger and NLTK tokenizer.
Regarding the challenging problems where there was more disagreement (less than 35% agreement) and, therefore, presented more difficulties for the tokenization tools are, the hypertext markup symbol, URLs and chemical substances. The latter was assumed since biomedical terminology is currently one of the most challenging research topics in NLP.
Among the cases with more than 80% agreement, it can be found: hyphenated compound words, words with letters and numbers, words with numbers and one type of punctuation and DNA sequences.
